Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Medical / Pharmaceuticals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 3

Put AI Label on It: Startup Aids Annotators of Healthcare Training Data
Put AI Label on It: Startup Aids Annotators of Healthcare Training Data
10/18/2019 12:06:58 PM
Deep learning applications are data hungry. The more high-quality labeled data a developer feeds an AI model, the more accurate its inferences. But creating robust datasets is the biggest obstacle for data scientists and developers building machine learning models, says Gaurav Gupta, CEO of TrainingData.io, a member of the NVIDIA Inception virtual accelerator program.
Report: Progress in Global Cancer Fight is not only Possible, but Achievable
Report: Progress in Global Cancer Fight is not only Possible, but Achievable
10/16/2019 10:57:24 AM
The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.
HCXI Releases Public Presentations on its Healthcare Visit App called vizSaver and Blockchain Based Risk Network.
HCXI Releases Public Presentations on its Healthcare Visit App called vizSaver and Blockchain Based Risk Network.
10/15/2019 4:42:06 PM
HCXI, INC, an AI and Blockchain enabled InsurTech company has released a public presentation on its HCXI risk management infrastructrure and its first use case called vizSaver.   The presentation  on “ HCXI Autonomous Risk Infrastructure and vizSaver Use Case” can be access via the HCXI  web site HERE The vizSaver overview  “Introducing an Insurance Risk Pool …
Broad market coverage for exclusive synthesis
Broad market coverage for exclusive synthesis
10/15/2019 2:49:44 PM
“Thanks to our many years of experience in the field of exclusive synthesis, we appeal not only to companies from the agrochemical and pharmaceutical industries, but also to other industries with demand for fine chemicals, such as the personal care sector,” explains Andreas Klein, head of Marketing and Sales at Saltigo GmbH, Leverkusen.
Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris
Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris
10/15/2019 2:30:45 PM
• 40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with MabThera/Rituxan compared to 9.5% of patients on mycophenolate mofetil • Study reinforces efficacy and safety of MabThera/Rituxan for treatment of PV, a rare autoimmune condition characterised by blistering of the …
QIAGEN launches new QIAseq FastSelect solutions to accelerate RNAseq
QIAGEN launches new QIAseq FastSelect solutions to accelerate RNAseq
10/15/2019 2:24:46 PM
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of innovative new technologies for faster, simpler library preparation for next-generation sequencing (NGS) in the growing field of RNA research.
U.S. FDA Approves XARELTO® (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients
U.S. FDA Approves XARELTO® (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients
10/15/2019 2:16:35 PM
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved XARELTO®  (rivaroxaban) for the prevention of venous thromboembolism (VTE), or blood clots, in hospitalized acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients
10/15/2019 12:35:23 PM
  Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio.
Agilent Early Career Professor Award Presented to Saeed Hassanpour
Agilent Early Career Professor Award Presented to Saeed Hassanpour
10/14/2019 1:16:23 PM
Agilent Technologies, Inc. (NYSE: A) today announced that Saeed Hassanpour, Ph.D., has received the 2019 Agilent Early Career Professor Award (AECPA).
Philips and Spencer Health Solutions expand partnership to Europe
Philips and Spencer Health Solutions expand partnership to Europe
10/14/2019 12:56:06 PM
Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced today the expansion of their partnership to Europe.
Mission Bio Awarded Grant to Measure Minimal Residual Disease Related to Cancer Relapse with Single Cell Genomics
10/10/2019 1:09:05 PM
Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced that it has been awarded a grant from the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) program to develop more advanced methods of quantifying molecular minimal residual disease (MRD) in acute myeloid leukemia (AML).
Sentio Solutions Raises $4.5M and Launches Feel to Expand Access to Mental Health Care and Provide On-Time Interventions to 500 Million People Living with Mental Health Issues Around the World
Sentio Solutions Raises $4.5M and Launches Feel to Expand Access to Mental Health Care and Provide On-Time Interventions to 500 Million People Living with Mental Health Issues Around the World
10/10/2019 1:00:00 PM
Sentio, a company developing biomarkers and digital therapeutics for mental health, today announced it has raised $4.5 million in seed funding led by Felicis Ventures, with participation from Anthemis Exponential Ventures,  and SOSV.
Environmental Testing for Acinetobacter and Other Drug-Resistant Pathogens in High Risk Environments in California
Environmental Testing for Acinetobacter and Other Drug-Resistant Pathogens in High Risk Environments in California
10/10/2019 8:40:41 AM
Earlier this year, the  Los Angeles Times  published an article about efforts scientists are taking to try and combat multidrug-resistant superbugs. The report specifically mentioned strains of  Acinetobacter  and several other microbial pathogens that are now resistant to most medicines that were once used to treat infections caused by these microorganisms.
Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx
Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx
10/8/2019 2:12:49 PM
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and Pfizer Inc. (NYSE:PFE), today announced that the companies have entered into a worldwide exclusive licensing agreement for AKCEA-ANGPTL3-LRx, an investigational antisense therapy being developed to treat patients with certain cardiovascular and metabolic …
P&R Dental Strategies Announces the Recipients of the 2019 DentaQual® Leaders in Quality® EliteStar® Dentist Awards
P&R Dental Strategies Announces the Recipients of the 2019 DentaQual® Leaders in Quality® EliteStar® Dentist Awards
10/8/2019 10:00:00 AM
P&R Dental Strategies, LLC, the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental payer objectives, today announced the list of recipients of the 2019 EliteStar Dentist Awards, a part of their DentaQual Leaders in Quality program.
As cholera continues to spread, UNICEF charters 1.6 million doses of vaccines to Sudan
As cholera continues to spread, UNICEF charters 1.6 million doses of vaccines to Sudan
10/8/2019 8:37:57 AM
UNICEF chartered a plane carrying 1.6 million doses of Oral Cholera Vaccines (OCV) to Khartoum yesterday. The vaccines arrived to Sudan at a critical time as cholera cases continue to be reported.
Urgent funding boost and
Urgent funding boost and "reality check" needed to sustain HIV and TB progress
10/8/2019 3:46:09 AM
A decline in international funding could reverse lifesaving gains and cause an “epidemic rebound” of HIV and tuberculosis (TB) in some countries, said Doctors Without Borders/Médecins Sans Frontières (MSF) Monday in a report released ahead of The Global Fund to Fight AIDS, Tuberculosis, and Malaria’s replenishment conference.
Two American Cancer Society Grantees Awarded Nobel Prize
Two American Cancer Society Grantees Awarded Nobel Prize
10/7/2019 10:25:14 AM
Two American Cancer Society grantees are among three recipients of the 2019 Nobel Prize in Physiology or Medicine. William G. Kaelin Jr and Gregg L.
Amar Gupta of MIT’s Institute of Medical Engineering and Science (IMES) Accepts
Editor-in-Chief Role at Telehealth and Medicine Today
Amar Gupta of MIT’s Institute of Medical Engineering and Science (IMES) Accepts Editor-in-Chief Role at Telehealth and Medicine Today
10/7/2019 8:00:00 AM
The online, peer-review journal  Telehealth and Medicine Today (TMT)  is honored to welcome Amar Gupta, PhD, as Editor-in-Chief.     “We are thrilled to have Dr.
Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen
Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen
10/7/2019 7:20:05 AM
AstraZeneca announced that the US Food and Drug Administration (FDA) has approved the self-administration of Fasenra (benralizumab) in a pre-filled, single-use auto-injector (the Fasenra Pen ).